92 related articles for article (PubMed ID: 25918011)
1. Endocytosis of ABCG2 drug transporter caused by binding of 5D3 antibody: trafficking mechanisms and intracellular fate.
Studzian M; Bartosz G; Pulaski L
Biochim Biophys Acta; 2015 Aug; 1853(8):1759-71. PubMed ID: 25918011
[TBL] [Abstract][Full Text] [Related]
2. Interaction with the 5D3 monoclonal antibody is regulated by intramolecular rearrangements but not by covalent dimer formation of the human ABCG2 multidrug transporter.
Ozvegy-Laczka C; Laczkó R; Hegedus C; Litman T; Várady G; Goda K; Hegedus T; Dokholyan NV; Sorrentino BP; Váradi A; Sarkadi B
J Biol Chem; 2008 Sep; 283(38):26059-70. PubMed ID: 18644784
[TBL] [Abstract][Full Text] [Related]
3. Function-dependent conformational changes of the ABCG2 multidrug transporter modify its interaction with a monoclonal antibody on the cell surface.
Ozvegy-Laczka C; Várady G; Köblös G; Ujhelly O; Cervenak J; Schuetz JD; Sorrentino BP; Koomen GJ; Váradi A; Német K; Sarkadi B
J Biol Chem; 2005 Feb; 280(6):4219-27. PubMed ID: 15557326
[TBL] [Abstract][Full Text] [Related]
4. Antibody binding shift assay for rapid screening of drug interactions with the human ABCG2 multidrug transporter.
Telbisz Á; Hegedüs C; Özvegy-Laczka C; Goda K; Várady G; Takáts Z; Szabó E; Sorrentino BP; Váradi A; Sarkadi B
Eur J Pharm Sci; 2012 Jan; 45(1-2):101-9. PubMed ID: 22115866
[TBL] [Abstract][Full Text] [Related]
5. Novel extracellular vesicles mediate an ABCG2-dependent anticancer drug sequestration and resistance.
Ifergan I; Scheffer GL; Assaraf YG
Cancer Res; 2005 Dec; 65(23):10952-8. PubMed ID: 16322243
[TBL] [Abstract][Full Text] [Related]
6. Caveolin-1 mediates chemoresistance in breast cancer stem cells via β-catenin/ABCG2 signaling pathway.
Wang Z; Wang N; Li W; Liu P; Chen Q; Situ H; Zhong S; Guo L; Lin Y; Shen J; Chen J
Carcinogenesis; 2014 Oct; 35(10):2346-56. PubMed ID: 25085904
[TBL] [Abstract][Full Text] [Related]
7. The nature of amino acid 482 of human ABCG2 affects substrate transport and ATP hydrolysis but not substrate binding.
Ejendal KF; Diop NK; Schweiger LC; Hrycyna CA
Protein Sci; 2006 Jul; 15(7):1597-607. PubMed ID: 16815914
[TBL] [Abstract][Full Text] [Related]
8. Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process.
Abrami L; Liu S; Cosson P; Leppla SH; van der Goot FG
J Cell Biol; 2003 Feb; 160(3):321-8. PubMed ID: 12551953
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine kinase inhibitors influence ABCG2 expression in EGFR-positive MDCK BCRP cells via the PI3K/Akt signaling pathway.
Pick A; Wiese M
ChemMedChem; 2012 Apr; 7(4):650-62. PubMed ID: 22354538
[TBL] [Abstract][Full Text] [Related]
10. Identification of residues in ABCG2 affecting protein trafficking and drug transport, using co-evolutionary analysis of ABCG sequences.
Haider AJ; Cox MH; Jones N; Goode AJ; Bridge KS; Wong K; Briggs D; Kerr ID
Biosci Rep; 2015 Jul; 35(4):. PubMed ID: 26294421
[TBL] [Abstract][Full Text] [Related]
11. Effect of Walker A mutation (K86M) on oligomerization and surface targeting of the multidrug resistance transporter ABCG2.
Henriksen U; Gether U; Litman T
J Cell Sci; 2005 Apr; 118(Pt 7):1417-26. PubMed ID: 15769853
[TBL] [Abstract][Full Text] [Related]
12. Localization of the human breast cancer resistance protein (BCRP/ABCG2) in lipid rafts/caveolae and modulation of its activity by cholesterol in vitro.
Storch CH; Ehehalt R; Haefeli WE; Weiss J
J Pharmacol Exp Ther; 2007 Oct; 323(1):257-64. PubMed ID: 17652262
[TBL] [Abstract][Full Text] [Related]
13. Lack of interaction between tauroursodeoxycholate and ATP-binding cassette transporter isoform G2 (ABCG2).
Vaidya SS; Gerk PM
Mol Pharm; 2006; 3(3):303-6. PubMed ID: 16749862
[TBL] [Abstract][Full Text] [Related]
14. N-Linked glycosylation of the human ABC transporter ABCG2 on asparagine 596 is not essential for expression, transport activity, or trafficking to the plasma membrane.
Diop NK; Hrycyna CA
Biochemistry; 2005 Apr; 44(14):5420-9. PubMed ID: 15807535
[TBL] [Abstract][Full Text] [Related]
15. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
[TBL] [Abstract][Full Text] [Related]
16. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells.
Kim M; Turnquist H; Jackson J; Sgagias M; Yan Y; Gong M; Dean M; Sharp JG; Cowan K
Clin Cancer Res; 2002 Jan; 8(1):22-8. PubMed ID: 11801536
[TBL] [Abstract][Full Text] [Related]
17. Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2.
Mizuarai S; Aozasa N; Kotani H
Int J Cancer; 2004 Mar; 109(2):238-46. PubMed ID: 14750175
[TBL] [Abstract][Full Text] [Related]
18. Structure of the human multidrug transporter ABCG2.
Taylor NMI; Manolaridis I; Jackson SM; Kowal J; Stahlberg H; Locher KP
Nature; 2017 Jun; 546(7659):504-509. PubMed ID: 28554189
[TBL] [Abstract][Full Text] [Related]
19. Strongly amphiphilic photosensitizers are not substrates of the cancer stem cell marker ABCG2 and provides specific and efficient light-triggered drug delivery of an EGFR-targeted cytotoxic drug.
Selbo PK; Weyergang A; Eng MS; Bostad M; Mælandsmo GM; Høgset A; Berg K
J Control Release; 2012 Apr; 159(2):197-203. PubMed ID: 22349185
[TBL] [Abstract][Full Text] [Related]
20. The antibody to GD3 ganglioside, R24, is rapidly endocytosed and recycled to the plasma membrane via the endocytic recycling compartment. Inhibitory effect of brefeldin A and monensin.
Iglesias-Bartolomé R; Crespo PM; Gomez GA; Daniotti JL
FEBS J; 2006 Apr; 273(8):1744-58. PubMed ID: 16623710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
